Advertisement

Journal of Cancer Education

, Volume 31, Issue 4, pp 693–701 | Cite as

Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey

  • Bryan LeyvaEmail author
  • Alexander Persoskie
  • Allison Ottenbacher
  • Jada G. Hamilton
  • Jennifer D. Allen
  • Sarah C. Kobrin
  • Stephen H. Taplin
Article

Abstract

Most professional organizations, including the American College of Physicians and U.S. Preventive Services Task Force, emphasize that screening for prostate cancer with the prostate-specific antigen (PSA) test should only occur after a detailed discussion between the health-care provider and patient about the known risks and potential benefits of the test. In fact, guidelines strongly advise health-care providers to involve patients, particularly those at elevated risk of prostate cancer, in a “shared decision making” (SDM) process about PSA testing. We analyzed data from the National Cancer Institute’s Health Information National Trends Survey 2011–2012—a nationally representative, cross-sectional survey—to examine the extent to which health professionals provided men with information critical to SDM prior to PSA testing, including (1) that patients had a choice about whether or not to undergo PSA testing, (2) that not all doctors recommend PSA testing, and (3) that no one is sure if PSA testing saves lives. Over half (55 %) of men between the ages of 50 and 74 reported ever having had a PSA test. However, only 10 % of men, regardless of screening status, reported receiving all three pieces of information: 55 % reported being informed that they could choose whether or not to undergo testing, 22 % reported being informed that some doctors recommend PSA testing and others do not, and 14 % reported being informed that no one is sure if PSA testing actually saves lives. Black men and men with lower levels of education were less likely to be provided this information. There is a need to improve patient-provider communication about the uncertainties associated with the PSA test. Interventions directed at patients, providers, and practice settings should be considered.

Keywords

Shared decision making PSA testing Prostate cancer screening Uncertainty Patient-provider communication 

Notes

Acknowledgments

The authors received no financial support for the research, authorship, and publication of this article. The views and opinions expressed in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health or any other government agency.

Conflict of Interest

The authors have no conflicts or financial interests to disclose.

References

  1. 1.
    Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29PubMedCrossRefGoogle Scholar
  2. 2.
    Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T et al (2011) Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol 18(5):5875–5883PubMedGoogle Scholar
  3. 3.
    Hayes JH, Barry MJ (2014) Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 311(11):1143–1149PubMedCrossRefGoogle Scholar
  4. 4.
    Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR et al (2012) Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 104(2):125–132PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Ilic D, Neuberger MM, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev 1:Cd004720PubMedGoogle Scholar
  7. 7.
    Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL et al (2013) Early detection of prostate cancer: AUA guideline. J Urol 190(2):419–426PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P (2013) Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 158(10):761–769PubMedCrossRefGoogle Scholar
  9. 9.
    Brooks DD, Wolf A, Smith RA, Dash C, Guessous I (2010) Prostate cancer screening 2010: updated recommendations from the American Cancer Society. J Natl Med Assoc 102(5):423–429PubMedCrossRefGoogle Scholar
  10. 10.
    Wolf AM, Wender RC, Etzioni RB, Thompson IM, D’Amico AV, Volk RJ et al (2010) American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 60(2):70–98PubMedCrossRefGoogle Scholar
  11. 11.
    Moyer VA (2012) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134PubMedCrossRefGoogle Scholar
  12. 12.
    Makoul G, Clayman ML (2006) An integrative model of shared decision making in medical encounters. Patient Educ Couns 60(3):301–312PubMedCrossRefGoogle Scholar
  13. 13.
    Hoffman RM, Helitzer DL (2007) Moving towards shared decision making in prostate cancer screening. J Gen Intern Med 22(7):1056–1057PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Han PKJ, Coates R, Uhler RJ, Breen N (2006) Decision making in prostate-specific antigen screening—National Health Interview Survey, 2000. Am J Prev Med 30(5):394–404PubMedCrossRefGoogle Scholar
  15. 15.
    Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL et al (2009) Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med 169(17):1611–1618PubMedCrossRefGoogle Scholar
  16. 16.
    Leader A, Daskalakis C, Braddock CH 3rd, Kunkel EJ, Cocroft JR, Bereknyei S et al (2012) Measuring informed decision making about prostate cancer screening in primary care. Med Decis Making 32(2):327–336PubMedCrossRefGoogle Scholar
  17. 17.
    Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG et al (2010) Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making 30(5 Suppl):53S–64SPubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J (1999) Informed consent for PSA screening: does it happen? Eff Clin Pract 2(4):152–157PubMedGoogle Scholar
  19. 19.
    Volk RJ, Linder SK, Kallen MA, Galliher JM, Spano MS, Mullen PD et al (2013) Primary care physicians’ use of an informed decision-making process for prostate cancer screening. Ann Fam Med 11(1):67–74PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Feng B, Srinivasan M, Hoffman JR, Rainwater JA, Griffin E, Dragojevic M et al (2013) Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits. Ann Fam Med 11(4):315–323PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Sahai V, Sharma A, Skandhan A, Lochinski K, Reese C (2010) Retrospective study to evaluate prostate cancer screening in a resident practice at a major teaching hospital. ASCO Annual Meeting Proceedings. p. e15008Google Scholar
  22. 22.
    Linder SK, Hawley ST, Cooper CP, Scholl LE, Jibaja-Weiss M, Volk RJ (2009) Primary care physicians’ reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey. BMC Fam Pract 10:19PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Dunn AS, Shridharani KV, Lou W, Bernstein J, Horowitz CR (2001) Physician-patient discussions of controversial cancer screening tests. Am J Prev Med 20(2):130–134PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Guerra CE, Jacobs SE, Holmes JH, Shea JA (2007) Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 22(7):901–907PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    (2008) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 149(3):185-91Google Scholar
  26. 26.
    Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL et al (2013) National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med 11(4):306–314PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ et al (2014) National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer 120(10):1491–1498PubMedCrossRefGoogle Scholar
  28. 28.
    U.S. Department of Health and Human Services. Healthy people 2020 topics & objectives: cancer. 2010. http://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives. Accessed 20 Oct 2014
  29. 29.
    Hoffmann TC, Montori VM, Del Mar C (2014) The connection between evidence-based medicine and shared decision making. JAMA 312(13):1295–1296PubMedCrossRefGoogle Scholar
  30. 30.
    Westat (2013) Health Information National Trends Survey 4 (HINTS 4) cycle 2 methodology report. Westat, RockvilleGoogle Scholar
  31. 31.
    Whitmore WF (1994) Localized prostatic-cancer—management and detection issues. Lancet 343(8908):1263–1267PubMedCrossRefGoogle Scholar
  32. 32.
    Frankel S, Smith GD, Donovan J, Neal D (2003) Screening for prostate cancer. Lancet 361(9363):1122–1128PubMedCrossRefGoogle Scholar
  33. 33.
    Hernandez J, Thompson IM (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101(5):894–904PubMedCrossRefGoogle Scholar
  34. 34.
    de Koning HJ, Auvinen A, Sanchez AB, da Silva FC, Ciatto S, Denis L et al (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97(2):237–244PubMedCrossRefGoogle Scholar
  35. 35.
    Levinson W, Kao A, Kuby A, Thisted RA (2005) Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med 20(6):531–535PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    van Ryn M (2002) Research on the provider contribution to race/ethnicity disparities in medical care. Med Care 40(1 Suppl):I140–I151PubMedGoogle Scholar
  37. 37.
    Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C et al (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282(6):583–589PubMedCrossRefGoogle Scholar
  38. 38.
    Rosen P, Anell A, Hjortsberg C (2001) Patient views on choice and participation in primary health care. Health Policy 55(2):121–128PubMedCrossRefGoogle Scholar
  39. 39.
    Gravel K, Legare F, Graham ID (2006) Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci 1:16PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Stacey D, Legare F, Col NF, Bennett CL, Barry MJ, Eden KB et al (2014) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 1:Cd001431PubMedGoogle Scholar
  41. 41.
    Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, Graham Ian D et al (2010) Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev 5:CD006732PubMedGoogle Scholar
  42. 42.
    Legare F, Turcotte S, Stacey D, Ratte S, Kryworuchko J, Graham ID (2012) Patients’ perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice. Patient 5(1):1–19PubMedCrossRefGoogle Scholar
  43. 43.
    Legare F, Ratte S, Gravel K, Graham ID (2008) Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’ perceptions. Patient Educ Couns 73(3):526–535PubMedCrossRefGoogle Scholar
  44. 44.
    Merenstein D (2004) A piece of my mind. Winners and losers. JAMA 291(1):15–16PubMedCrossRefGoogle Scholar
  45. 45.
    Volk RJ, Hawley ST, Kneuper S, Holden W, Stroud LA, Cooper CP et al (2007) Trials of decision aids for prostate cancer screening—a systematic review. Am J Prev Med 33(5):428–434PubMedCrossRefGoogle Scholar
  46. 46.
    Cooper CP, Merritt TL, Ross LE, John LV, Jorgensen CM (2004) To screen or not to screen, when clinical guidelines disagree: primary care physicians’ use of the PSA test. Prev Med 38(2):182–191CrossRefGoogle Scholar
  47. 47.
    Guerra CE, Gimotty PA, Shea JA, Pagan JA, Schwartz JS, Armstrong K (2008) Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey. Med Decis Making 28(5):681–689PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Edwards A, Elwyn G, Hood K, Atwell C, Robling M, Houston H et al (2004) Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract 21(4):347–354PubMedCrossRefGoogle Scholar
  49. 49.
    Stacey D, O’Connor AM, Graham ID, Pomey MP (2006) Randomized controlled trial of the effectiveness of an intervention to implement evidence-based patient decision support in a nursing call centre. J Telemed Telecare 12(8):410–415PubMedCrossRefGoogle Scholar
  50. 50.
    O’Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H et al (1999) Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 319(7212):731–734PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M et al (2011) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 10:CD001431PubMedGoogle Scholar
  52. 52.
    Stacey D, Samant R, Bennett C (2008) Decision making in oncology: a review of patient decision aids to support patient participation. CA Cancer J Clin 58(5):293–304PubMedCrossRefGoogle Scholar
  53. 53.
    Joseph-Williams N, Edwards A, Elwyn G (2014) Power imbalance prevents shared decision making. BMJ 348:g3178PubMedCrossRefGoogle Scholar
  54. 54.
    Legare F, Stacey D, Pouliot S, Gauvin FP, Desroches S, Kryworuchko J et al (2011) Interprofessionalism and shared decision-making in primary care: a stepwise approach towards a new model. J Interprof Care 25(1):18–25PubMedCrossRefGoogle Scholar
  55. 55.
    Legare F, Stacey D, Briere N, Desroches S, Dumont S, Fraser K et al (2011) A conceptual framework for interprofessional shared decision making in home care: protocol for a feasibility study. BMC Health Serv Res 11:23PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Golanowski M, Beaudry D, Kurz L, Laffey WJ, Hook ML (2007) Interdisciplinary shared decision-making: taking shared governance to the next level. Nurs Adm Q 31(4):341–353PubMedCrossRefGoogle Scholar
  57. 57.
    Jordan TR, Price JH, King KA, Masyk T, Bedell AW (1999) The validity of male patients’ self-reports regarding prostate cancer screening. Prev Med 28(3):297–303PubMedCrossRefGoogle Scholar
  58. 58.
    Chan ECY, Vernon SW, Ahn C, Greisinger A (2004) Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health 94(8):1336–1338PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Arora NK, Hesse BW, Clauser SB (2015) Walking in the shoes of patients, not just in their genes: a patient-centered approach to genomic medicine. Patient 8(3):239–245PubMedCrossRefGoogle Scholar
  60. 60.
    Epstein RM, Street RL (2011) The values and value of patient-centered care. Annals Fam Med 9(2):100–103CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2015

Authors and Affiliations

  • Bryan Leyva
    • 1
    Email author
  • Alexander Persoskie
    • 2
  • Allison Ottenbacher
    • 3
  • Jada G. Hamilton
    • 4
  • Jennifer D. Allen
    • 5
  • Sarah C. Kobrin
    • 1
  • Stephen H. Taplin
    • 1
  1. 1.Process of Care Research Branch, Behavioral Research ProgramNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research ProgramNational Cancer Institute, National Institutes of HealthBethesdaUSA
  3. 3.Science of Research and Technology Branch, Behavioral Research ProgramNational Cancer Institute, National Institutes of HealthBethesdaUSA
  4. 4.Department of Psychiatry and Behavioral SciencesMemorial Sloan Kettering Cancer CenterNew YorkUSA
  5. 5.Department of Public Health and Community MedicineTufts UniversityBostonUSA

Personalised recommendations